Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma

Abstract

TILs and PD-L1 expression are detectable in the majority of glioblastoma samples but are not related to outcome. Because the target is present, a clinical study with specific immune checkpoint inhibitors seems to be warranted in glioblastoma.